SCHEMBL8273653

SCHEMBL8273653

Cc1cc(NC(=O)C(C)c2nc3ccc(Cl)cc3[nH]2)ccc1C(=O)N1CCOCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MOK Q9UQ07 3/20 0.46
EPHX2 P34913 1/20 0.44
HRH4 Q9H3N8 3/20 0.44
HRH3 Q9Y5N1 1/20 0.44
AKT1 P31749 1/20 0.43
GPR35 Q9HC97 1/20 0.43
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 2/20 0.41
NPC1 O15118 2/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 2/20 0.41
ALOX15 P16050 1/20 0.41
KMT2A Q03164 2/20 0.40
RAB9A P51151 1/20 0.40
MEN1 O00255 1/20 0.40
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4925760 0.93 EPHX2 (0.44) MOKEPHX2HRH3AKT1GPR35
SCHEMBL14281189 0.87 DPP4 (0.42) HRH4HRH3SMN1; SMN2ALDH1A1HPGD
SCHEMBL4916310 0.85 HRH4 (0.42) HRH4HRH3ALDH1A1NPC1MAPT
SCHEMBL8272905 0.83 MLLT1 (0.48) HRH4HRH3ALDH1A1HPGDHTT
SCHEMBL8273650 0.82 HRH4 (0.43) HRH4HRH3SMN1; SMN2ALDH1A1NPC1
SCHEMBL14281186 0.81 F10 (0.55)
SCHEMBL4915184 0.80 CCKBR (0.38) HRH4HRH3AKT1SMN1; SMN2ALDH1A1
SCHEMBL8272693 0.80 HRH4 (0.43) HRH4HRH3ALDH1A1MAPTHPGD
SCHEMBL8274765 0.79 HRH4 (0.42) HRH4HRH3SMN1; SMN2HPGDALOX15
SCHEMBL8274771 0.78 HRH4 (0.43) HRH4HRH3ALDH1A1MAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080015178-A1 BENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND USE THEREOF AS MEDICAMENT GERLACH KAI 2008-01-17 US disclosed
US-20080015178-A1 BENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND USE THEREOF AS MEDICAMENT GERLACH KAI 2008-01-17 US disclosed
WO-2005121103-A1 BENZIMIDAZOLES, METHOD FOR PRODUCING THEM AND THE USE THEREOF AS DRUGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015178-A1 BENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND USE THEREOF AS MEDICAMENT CYP2C19, CYP3A4, CYP2B6 MOK 2871/4885EPHX2 3826/4885HRH4 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.